Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 77, Issue 2, 1993, Pages 510-517

  Enjoh, Tomoko ^a   Hizuka, Naomi ^b   Perdue, James F ^c   Takano, Kazue ^b   Fujiwara, Hiroyuki ^a   Higashihashi, Nobuyuki ^a   Marumoto, Yasumasa ^a   Fukuda, Izumi ^b   Sakano, Katsu Ichi ^a  

^a DAIICHI SANKYO CO   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; AGED; AMINO ACID COMPOSITION; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOBLOTTING; MALE; PANCREAS TUMOR; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; EPITOPES; FEMALE; HUMAN; HYPOGLYCEMIA; IMMUNOGLOBULIN G; INSULIN-LIKE GROWTH FACTOR II; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGE; MOLECULAR WEIGHT; NEOPLASMS; RADIOIMMUNOASSAY; RATS; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027290771     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.77.2.7688378     Document Type: Article

References (25)

1. Hampton B, Burgess WH, Marshak DR, Cullen KJ, Perdue JF. 1989 Purification and characterization of an insulin-like growth factor II variant from human plasma. J Biol Chem. 264:19155-19160.
2. Hudgins WR, Hampton B, Burgess WH, Perdue JF. 1992 The identification of O-glycosylated precursors of insulin-like growth factor II. J Biol Chem. 267:8153-8160.
3. Zumstein PP, Lüthi C, Humbel E. 1985 Amino add sequence of a variant proform of insulin-like growth factor II. Proc Natl Acad Sd USA. 82:3169-3172.
4. Daughaday WH. 1991 Autocrine, paracrine, and endocrine manifestations of insulin-like growth factor secretion by tumors. In: Spencer EM, ed. Modem concepts of insulin-like growth factors. New York: Elsevier; pp 557-565.
5. Teale JD, Marks V. 1990 Inappropriately elevated plasma insulinlike growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycemia. Clin Endocrinol (Oxf). 33:87-98.
6. Daughaday WH, Trivedi B, Kapadia M. 1981 Measurement of insulin-like growth factor II by a spedfic radioreceptor assay in serum of normal individuals patients with abnormal growth hormone secretion and patients with tumor-assodated hypoglycemia. J Clin Endocrinol Metab. 53:289-294.
7. Baxter RC, de Mellow JS. 1986 Measurement of insulin-like growth factor-II by radioreceptor assay using ovine placental membranes. Clin Endocrinol (Oxf). 24:267-278.
8. Hintz RL, Liu F. 1982 A radioimmunoassay for insulin-like growth factor II spedfic for the C-peptide region. J Clin Endocrinol Metab. 54:442-446.
9. Blum WF, Ranke MB, Bierich JR. 1988 A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF- I Acta Endocrinol (Copenh). 118:374-380.
10. Zapf J, Walter H, Froesch ER. 1981 Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest. 68:1321-1330.
11. Tanaka H, Asami O, Hayano T, Sasaki I, Yoshitake Y, Nishikawa K. 1989 Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18, 54-SF: Application of a monoclonal antibody. Endocrinology. 124:870-877.
12. Clemmons DR. 1991 Insulin-like growth factor binding proteins. In: LeRoith D, ed. Insulin-like growth factors: molecular and cellular aspects. Boca Raton: CRC Press; pp 151-179.
13. Zapf J, Schmid Ch, Guler HP, et al. 1990 Regulation of binding proteins for insulin-like growth factors (IGF) in humans: increased expression of IGF binding protein 2 during IGF-I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest. 86:952-961.
14. Daughaday WH. 1987 Radioligand assays for insulin-like growth factor II. Methods Enzymol. 146:248-259.
15. Perdue JF, Gowan LK, Hudgins WR, Scheuermann J, Foster B, Brown SN. 1991 Development of a specific radioimmunoassay for E domain containing forms of insulin-like growth factor II. Adv Exp Med Biol. 293:45-56.
16. Daughaday WH, Trivedi B. 1992 Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab. 75:110-115.
17. Marumoto Y, Teruuchi T, Enjoh T, Numata F, Sakano K. 1992 Purification and refolding of recombinant human IGF-II from silkworms infected with recombinant Bombyx mori nuclear polyhedrosis virus. Biosci Biotech Biochem. 56:13-16.
18. Sakano K, Enjoh T, Numata F, et al. 1991 The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor. J Biol Chem. 266:20626-20635.
19. Daughaday WH, Mariz IK, Blethen SL. 1980 Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of so-matomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab. 51:781-788.
20. Laemmli UK. 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
21. Asakawa K, Hizuka N, Takano K, et al. 1990 Radioimmunoassay for insulin-like growth factor II (IGF-II). Endocrinol Jpn 37:607-614.
22. Smith MC, Cook JA, Furman TC, Occolowitz JL. 1989 Structure and activity dependence of recombinant human insulin-like growth factor II on disulfide bond pairing. J Biol Chem. 264:9314-9321.
23. Teale JD, Blum WF, Marks V. 1992 Alleviation of non-islet cell tumor hypoglycemia by growth hormone therapy is associated with changes in IGF binding protein-3. Ann Clin Biochem. 29:314-323.
24. Davenport ML, Svoboda ME, Koerber KI, Van Wyk JJ, Clemmons DR, Underwood LE. 1988 Serum concentrations of insulin-like growth factor II are not changed by short term fasting and refeeding. J Clin Endocrinol Metab. 67:1231-1236.
25. Bowsher RR, Lee WH, Apathy JM, O’Brien PJ, Ferguson AL, Henry D P. 1991 Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids. Endocrinology. 128:805-814.